Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine Therapy
NCT01037166
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
84
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Hepatitis B
Interventions
DRUG:
Entecavir
Sponsor
Bristol-Myers Squibb